← Volver a la listaCompanyIncheon Startup Park is the first space in Korea where the public and private sectors collaborate to nurture startups. It consists of InSta I, operated by a public institution (Incheon Technopark), and InSta II, operated by a private company (Shinhan Financial Group). Here, we introduce the representative resident empresas of InSta I.
These startups han sido reconocido for the future value of their products and the crecimiento potential of their empresas, having been seleccionada for Korea's highest-level startup preferential programas, and they are spreading their wings wide to leap toward becoming 'unicorn empresas' — startups valued at over USD 1 billion.
RudaCure Inc. (CEO Yongho Kim), which leverages basic biomedical investigación to present a new paradigm in desarrollo de nuevos fármacos capable of achieving fundamental tratamiento for intractable conditions, is working on developing a tratamiento de la enfermedad de ojo seco without efectos secundarios and a non-addictive tratamiento del dolor.
Focusing on the mercado for age-related eye diseases, la empresa has gained attention for developing and patenting eye drops for treating ocular conditions such as enfermedad de ojo seco. ← Volver a la lista
¿Quién será el futuro unicornio? Incheon Startup Park construye el camino
2021-07-16
These startups han sido reconocido for the future value of their products and the crecimiento potential of their empresas, having been seleccionada for Korea's highest-level startup preferential programas, and they are spreading their wings wide to leap toward becoming 'unicorn empresas' — startups valued at over USD 1 billion.
RudaCure Inc. (CEO Yongho Kim), which leverages basic biomedical investigación to present a new paradigm in desarrollo de nuevos fármacos capable of achieving fundamental tratamiento for intractable conditions, is working on developing a tratamiento de la enfermedad de ojo seco without efectos secundarios and a non-addictive tratamiento del dolor.
Focusing on the mercado for age-related eye diseases, la empresa has gained attention for developing and patenting eye drops for treating ocular conditions such as enfermedad de ojo seco.